Idaho lawmaker wants to limit the cost of certain anticancer drugs. What to know
Cancer patients in
A new bill moving through the Legislature aims to create fairness in what patients pay for anticancer drugs, regardless of whether those medications come in pill form or are delivered by injection or intravenous infusion.
House Bill 530, introduced by the
Under the proposed legislation, insurance plans must either set the copayments, deductibles or coinsurance amounts for oral anticancer medications at no higher than those for injected or intravenously administered anticancer medications, or they must cap the monthly out-of-pocket costs for oral anticancer medications at
The bill would also prevent insurance companies from sidestepping the rules by increasing the copayment, deductible or coinsurance required for anticancer medications covered by health insurance plans or by reclassifying anticancer drugs in the plans.
Republican Rep.
Other supporters argued that the bill levels the playing field for all cancer patients and allows doctors and patients to make treatment decisions based on medical need and not the patient’s pocketbook.
Lawmakers on the committee voted to send it to the full House with a do-pass recommendation. If passed and signed into law, the bill would take effect
What happened to that
Providers said people would die if
©2026 The Idaho Statesman. Visit idahostatesman.com. Distributed by Tribune Content Agency, LLC.



When the Gulf Heats Up, India Is the First to Pay
AI super PAC announces $5M investment boosting Byron Donalds
Advisor News
- Advisors must lead the policy risk conversation
- Gen X more anxious than baby boomers about retirement
- Taxing trend: How the OBBBA is breaking the standard deduction reliance
- Why advisors can’t afford to delay succession planning
- 6 in 10 Americans struggle with financial decisions
More Advisor NewsAnnuity News
- CT commissioner: 70% of policyholders covered in PHL liquidation plan
- ‘I get confused:’ Regulators ponder increasing illustration complexities
- Three ways the Corebridge/Equitable merger could shake up the annuity market
- Corebridge, Equitable merge to create potential new annuity sales king
- LIMRA: Final retail annuity sales total $464.1 billion in 2025
More Annuity NewsHealth/Employee Benefits News
- Advocates call for hearing about Geisinger-Risant insurance condition change request
- Tucson Speaks Out: April 5
- El Rio taps experienced leader to oversee transition from North Country HealthCare to Elk Ridge
- Red ink at Minnesota Blue Cross spells more Medicare Advantage troubles ahead
- MEDICAID COST-SHARING LIMITATIONS AMENDED, ADVANCED
More Health/Employee Benefits NewsLife Insurance News
- WHAT THEY ARE SAYING: KATHLEEN COULOMBE JOINS ACU AS CHIEF ADVOCACY OFFICER
- A-CAP Appoints Kirk Cullimore as President of Sentinel Security Life
- Nationwide enters centennial year stronger than ever
- AM Best Affirms Credit Ratings of Mutual of Omaha Insurance Company and Its Subsidiaries
- AM Best Affirms Credit Ratings of CMB Wing Lung Insurance Company Limited
More Life Insurance News